Rockwell Medical (RMTI) Q2 FY26 earnings call

Rockwell Medical delivered a strong second quarter, marked by double-digit net sales growth, significant gross margin expansion, and positive operating cash flow, reinforcing the effectiveness of its strategic initiatives. The company continues to diversify its customer base and invest in operational efficiencies, positioning itself for long-term profitability and value creation, while also exploring new medical device opportunities within its renal care platform.